CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Travere Therapeutics Insider Sold Shares Worth $25,390,729, According to a Recent SEC Filing

Neutral
AI Analysis

Summary

Travere Therapeutics insider sold shares worth $25,390,729 according to SEC filing. This is a routine disclosure of insider trading activity.

Importance:2/10
Sentiment:
0.00
insider sellingSEC filing
Related Companies

Read the original article

Published by yahoo_finance on September 18, 2026 7:43 AM

Read Original